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Abstract
We investigated the molecular mechanism involved in the adaptive regulation of the amino acid transport system A, a
process in which amino acid starvation induces the transport activity. These studies were done with rat C6 glioma cells.
System A activity in these cells is mediated exclusively by the system A subtype, amino acid transporter A2 (ATA2). The
other two known system A subtypes, ATA1 and ATA3, are not expressed in these cells. Exposure of these cells to an amino
acid-free medium induces system A activity. This process consists of an acute phase and a chronic phase. Laser-scanning
confocal microscopic immunolocalization of ATA2 reveals that the acute phase is associated with recruitment of preformed
ATA2 from an intracellular pool to the plasma membrane. In contrast, the chronic phase is associated with an induction of
ata2 gene expression as evidenced from the increase in the steady-state levels of ATA2 mRNA, restoration of the intracellular
pool of ATA2 protein, and blockade of the induction by cycloheximide and actinomycin D. The increase in system A activity
induced by amino acid starvation is blocked specifically by system A substrates, including the non-metabolizable K-
(methylamino)isobutyric acid. ß 2001 Elsevier Science B.V. All rights reserved.
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System A is a Na-dependent active transport sys-
tem for neutral amino acids expressed in most tissues
[1]. A unique characteristic of this system is its ability
to recognize N-alkylated amino acids as substrates
[2]. K-(Methylamino)isobutyric acid (MeAIB) is rou-
tinely used as a model substrate for system A. Even
though system A has been well recognized for its
regulation [3^5], this phenomenon has so far been
studied only at phenomenological level. The lack of
molecular tools such as transporter-speci¢c antibod-
ies and cDNA probes precluded studies on the mo-
lecular mechanisms involved in the regulatory pro-
cesses. Only recently, the molecular identity of the
amino acid transport system A has been established
[6^13]. Interestingly, these recent studies have identi-
¢ed three distinct transporter proteins that are capa-
ble of mediating the Na-dependent transport of the
system A model substrate MeAIB. The three trans-
porters are known as amino acid transporter A
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(ATA)1, ATA2, and ATA3 [6^13]. ATA1 and ATA2
possess similar functional characteristics, but exhibit
di¡erential tissue expression pattern. ATA1 is ex-
pressed primarily in the placenta and brain whereas
ATA2 is expressed ubiquitously in mammalian tis-
sues. In contrast, ATA3 is functionally distinguish-
able from ATA1 and ATA2. Furthermore, the ex-
pression of ATA3 is almost strictly restricted to the
liver. Based on these ¢ndings, only ATA2 represents
the ubiquitously expressed system A transporter that
is particularly known for its regulation.
The present study was undertaken to investigate
the molecular mechanisms involved in the sub-
strate-induced adaptive regulation of ATA2. Phe-
nomenologically, the term ‘adaptive regulation’ re-
fers to a process in which the activity of system A
is up-regulated when cells are cultured in an amino
acid-free medium and restoration of amino acid
availability to the cells reverses the up-regulation
[3^5]. The ability to regulate system A in this process
is almost strictly restricted to the substrates of system
A. To study the molecular events involved in this
process, we selected the rat C6 glioma cells because
these cells express only ATA2. Absence of ATA1 and
ATA3 makes these cells ideal for studies involving
the regulation of ATA2.
C6 glioma cells (American Type Culture Collec-
tion, Manassas, VA, USA) were cultured in mini-
mum essential medium, supplemented with 10% fetal
bovine serum, 100 U/ml penicillin and 100 Wg/ml
streptomycin. Cells were seeded in 24-well culture
plates and characterization of the transport of
[14C]MeAIB (American Radiolabeled Chemicals, St.
Louis, MO, USA) was done with con£uent cells. For
studies involving adaptive regulation, con£uent cells
were exposed to either the regular culture medium
(without the fetal bovine serum) or an amino acid-
free salt solution for desired time periods, following
which the transport of MeAIB was measured. The
composition of the amino acid-free salt solution was
25 mM HEPES/Tris (pH 7.5) containing 140 mM
NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4,
and 5 mM glucose. The same salt solution, after ad-
justing the pH to 8.5, was used as the uptake bu¡er
for measurement of MeAIB transport. Transport
was measured at 37‡C with a 15 min incubation as
described previously [8,9]. The transport of MeAIB
in these cells was linear even up to 45 min.
The expression of di¡erent subtypes of system A in
the rat brain and liver and in C6 glioma cells was
analyzed by reverse transcription-polymerase chain
reaction (RT-PCR). Poly(A) RNA was isolated
from C6 glioma cells, rat cerebral cortex, rat cerebel-
lum, and rat liver. RT-PCR was done with primer
pairs speci¢c for rat ATA1, ATA2, and ATA3. A
primer pair speci¢c for rat glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) was used as an
internal control. The primer pairs used were as
follows: 5P-ACGACTCTAATGACTTCACGG-3P
(sense) and 5P-ACTTACTGTTGAGTTCTGTTC-3P
(antisense) for ATA1; 5P-AACTACTCATACCC-
CACGAAG-3P (sense) and 5P-AAAGGTGCCATT-
CACCGTTTC-3P (antisense) for ATA2; 5P-AG-





Northern blot hybridization was carried out using
poly(A) RNA isolated from control and treated C6
glioma cells. The mRNA samples were size-fraction-
ated on a denaturing formaldehyde-agarose gel and
probed with [32P]labeled rat ATA2 cDNA and rat
GAPDH cDNA.
An anti-peptide antibody speci¢c for rat ATA2,
generated in rabbit, was used for immunolocalization
of ATA2 in C6 glioma cells. The sequence of the
antigenic peptide is DEDSSSYSSNGDFNYSYPTK-
QAA. This amino acid sequence is located in the N-
terminal tail of rat ATA2 (amino acid positions 14^
36) and is signi¢cantly di¡erent from the correspond-
ing sequences in rat ATA1 and rat ATA3. In this
region, only six amino acids are identical between
ATA2 and ATA3 and only one amino acid is iden-
tical between ATA2 and ATA1. To assess the spe-
ci¢city of the antibody, we expressed rat ATA1,
ATA2, and ATA3 heterologously in human retinal
pigment epithelial cells using the vaccinia virus ex-
pression system as described previously [8] and used
the membranes from these cells for Western analysis
(data not shown). Vector-transfected cells served as
the negative control. The antibody detected a 48 kDa
protein in cells expressing rat ATA2. There was no
immunoreactive protein detectable in vector-trans-
fected cells and in cells expressing rat ATA1 and
rat ATA3.
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For laser-scanning confocal microscopic analysis
of ATA2, C6 glioma cells were seeded on eight-well
chamber slides and grown to con£uency. Con£uent
cells were then exposed either to the regular culture
medium or to the amino acid-free salt medium for
1 or 8 h. After treatment, the cells were prepared for
laser-scanning confocal microscopic immunodetec-
tion of ATA2 as described previously [14]. The cells
were ¢xed with ice-cold methanol and blocked with
10% normal goat serum. Incubation with the anti-
ATA2 antibody was done for 3 h at room temper-
ature. Incubation with 0.1% normal rabbit serum
served as negative controls. After rinsing, cells were
incubated overnight at 4‡C with a £uorescein isothio-
cyanate-conjugated A⁄niPure goat anti-rabbit IgG.
Cells were then optically sectioned (z series) using a
Nikon Diaphot 200 Laser-scanning Confocal Imag-
ing System (Molecular Dynamics, Sunnyvale, CA,
USA). Analyses of images were done using the Image
Display 3.2 software package (Silicon Graphics,
Mountain View, CA, USA).
To determine at the functional level which of the
three subtypes of system A is/are expressed in the rat
C6 glioma cells, the transport characteristics of
MeAIB were ¢rst elucidated. The transport of
MeAIB in these cells was Na-dependent. The sys-
tem was speci¢c for short-chain neutral amino acids
as well as for glutamine and asparagine, but did not
interact with anionic and cationic amino acids. The
Na :MeAIB stoichiometry was 1:1. The Michaelis^
Menten constant (Kt) for MeAIB was 0.26 þ 0.02
mM. These functional characteristics of MeAIB
transport in C6 glioma cells are similar to those de-
scribed for ATA1 and ATA2 [6^11]. Both of these
subtypes exclude anionic and cationic amino acids
and exhibit a Kt value for MeAIB in the range of
0.2^0.3 mM. In contrast, ATA3 accepts cationic ami-
no acids as substrates and has a Kt value for MeAIB
in the range of 6^10 mM [12,13]. These data show
that MeAIB transport in C6 glioma cells is mediated
by ATA1 and/or ATA2, but not by ATA3.
Fig. 1 describes the results of RT-PCR for the
molecular identity of the system A subtype that is
expressed in C6 glioma cells. These cells express
only ATA2 whereas cerebral cortex and cerebellum
express both ATA1 and ATA2. The expression of
ATA1 as well as ATA2 in rat brain corroborates
the results from previous studies [6^11]. Rat liver
was used as a positive control for ATA3 expression
and, as expected, poly(A) RNA from this tissue
yielded the RT-PCR product for ATA3. RT-PCR
was positive for GAPDH mRNA with all poly(A)
RNA samples. These data demonstrate that while the
brain expresses ATA1 as well as ATA2, C6 glioma
cells express only ATA2. ATA3 is not expressed in
these cells nor in the brain.
The in£uence of amino acid starvation on the ac-
tivity of system A was studied in C6 glioma cells by
exposing the cells either to a complete medium or to
an amino acid-free salt medium for varying periods
of time and then assaying the transport of MeAIB.
Exposure of the cells to the amino acid-free medium
Fig. 1. Evidence for the expression of only ATA2 in C6 glioma
cells. Poly(A) RNA from C6 glioma cells, rat cerebral cortex,
rat cerebellum, and rat liver was subjected to RT-PCR using
primer pairs speci¢c for rat ATA1, ATA2, ATA3 and
GAPDH.
Fig. 2. Stimulation of system A activity induced by amino acid
starvation. C6 glioma cells were exposed either to a complete
medium (medium) or to an amino acid-free medium (bu¡er) for
di¡erent time periods and then the transport of MeAIB (10
WM) was measured.
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induced the activity of system A (Fig. 2). A signi¢-
cant induction (V25%) was seen even with 1 h ex-
posure and the magnitude of induction increased as
the exposure time increased. With 8 h exposure, the
induction was 2.9-fold. There was no further change
in the magnitude of induction when the exposure
time was extended beyond 8 h (data not shown).
The induction was speci¢c for system A because
the transport of glutamate and arginine was not af-
fected under similar conditions (1 or 8 h exposure)
(data not shown).
The saturation kinetics of MeAIB transport were
then analyzed in control cells cultured in complete
medium and in cells exposed to the amino acid-free
salt medium for 8 h (Fig. 3A). The increase in the
activity of system A caused by amino acid starvation
was associated with an increase in the maximal ve-
locity (Vmax) of the transport system (control,
52.5 þ 1.3 nmol/mg of protein/15 min; amino acid
starvation, 147.6 þ 2.8 nmol/mg of protein/15 min).
The a⁄nity of the transport system for MeAIB re-
mained essentially unaltered. The values for Kt in
control and in amino acid-starved cells were
0.26 þ 0.02 and 0.34 þ 0.01 mM, respectively. We
then studied the possible role of RNA and protein
synthesis in the adaptive regulation of system A. The
in£uence of amino acid starvation on system A ac-
tivity was attenuated signi¢cantly by cycloheximide
(an inhibitor of protein synthesis) and actinomycin D
(an inhibitor of RNA synthesis) (Fig. 3B). Taken
collectively, these data show that chronic exposure
(8 h) of the cells to an amino acid-free medium in-
duces the system A activity most likely by enhancing
de novo synthesis of the transporter protein and con-
sequently increasing the density of the transporter
protein in the plasma membrane.
We then investigated the ability of individual ami-
no acids to reverse the in£uence of amino acid star-
vation on system A activity (Fig. 4A). As seen pre-
viously, exposure of the cells to an amino acid-free
medium for 8 h induced system A activity by 2.5-
fold. However, when the amino acid-free salt me-
dium was supplemented with 1 mM MeAIB, gluta-
mine, or asparagine, the induction was almost totally
abolished. These three amino acids are substrates of
system A and they were capable of reversing the
in£uence of amino acid starvation on system A ac-
tivity. In contrast, arginine was unable to reverse the
Fig. 3. (A) Saturation kinetics of MeAIB transport. C6 glioma
cells were exposed either to a complete medium (medium) or to
an amino acid-free medium (bu¡er) for 8 h and then the trans-
port of MeAIB was measured over the concentration range of
0.025^2.5 mM. Results are given as Eadie^Hofstee plots. V,
MeAIB transport in nmol/mg/15 min; S, MeAIB concentration
in mM. (B) In£uence of cycloheximide and actinomycin D. C6
glioma cells were ¢rst treated for 2 h with or without cyclohexi-
mide (CHX, 75 Wg/ml) or actinomycin D (ACD, 7.5 Wg/ml).
Cells were then exposed either to a complete medium (M) or to
an amino acid-free medium (UB) in the presence or absence of
cycloheximide or actinomycin D for 8 h. The transport of
MeAIB (10 WM) was then measured. Values in parentheses are
percent of respective control transport measured in cells ex-
posed to the complete medium.
C
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in£uence of amino acid starvation. Arginine is not a
substrate for ATA2. Northern blot analysis showed
that amino acid starvation for 8 h increased the
abundance of ATA2 mRNA by 2.7-fold. Addition
of 1 mM MeAIB, glutamine, or asparagine to the
amino acid-free salt medium abolished this increase
in ATA2 mRNA abundance completely (Fig. 4B,C).
Arginine did not have any e¡ect on the increase in
ATA2 mRNA abundance induced by amino acid
starvation. These results show that chronic exposure
of C6 glioma cells to an amino acid-free medium
increases the steady-state levels of ATA2 mRNA
and that the substrates of system A speci¢cally re-
verse this e¡ect.
We then analyzed the ATA2 protein expression in
control cells cultured in the complete medium and in
cells exposed to an amino acid-free salt medium (1 or
8 h). Laser-scanning confocal microscopic immuno-
localization of the ATA2 protein showed that the
increase in system A activity associated with acute
exposure (1 h) of the cells to the amino acid-free
medium is due to transporter recruitment from an
intracellular pool to the plasma membrane (Fig.
5A,B). In cells cultured in the complete medium,
ATA2 protein was detectable in the plasma mem-
brane as well as in the cytoplasm (Fig. 5A, B). In
contrast, the levels of ATA2 protein in the plasma
membrane increased with a concomitant decrease in
the cytoplasmic levels of the protein in cells exposed
for 1 h to the amino acid-free medium (Fig. 5C, D).
However, when the cells were exposed for 8 h to the
amino acid-free medium, the cytoplasmic pool of the
transporter protein was restored (Fig. 5G, H). The
expression pattern of ATA2 in cells cultured for 8 h
in the complete medium was not di¡erent from that
in cells cultured for 1 h in the same complete medium
(Fig. 5E, F). These results show that di¡erent mech-
anisms operate to increase system A activity in the
acute and chronic phases of amino acid starvation.
In the acute phase, amino acid starvation stimulates
the recruitment of ATA2 from an intracellular pool
to the plasma membrane, thus resulting in an in-
crease in system A activity. The increase is small in
magnitude, but the response is quick. This e¡ect of
amino acid starvation on the translocation of ATA2
is analogous to the in£uence of insulin on GLUT4 in
adipocytes and skeletal muscle [15^17]. In the
chronic phase, amino acid starvation activates ata2
gene expression and enhances de novo synthesis of
ATA2. This causes a much larger increase in system
A activity compared to the acute phase response.
These studies describe for the ¢rst time the molec-
ular mechanisms involved in the adaptive regulation
of system A. The regulation consists of an acute
phase involving the recruitment of preformed trans-
porter protein from an intracellular pool to the plas-
Fig. 4. In£uence of system A substrates on amino acid starva-
tion-induced changes in system A activity and in ATA2 mRNA
levels. C6 glioma cells were exposed to a complete medium (1),
an amino acid-free medium (2), or the amino acid-free medium
supplemented with 1 mM MeAIB (3), glutamine (4), asparagine
(5) or arginine (6) for 8 h. The transport of MeAIB (10 WM)
was then measured. Poly(A) RNA was isolated from these
cells and subjected to Northern blot hybridization with [32P]-la-
beled cDNA probes speci¢c for ATA2 and GAPDH. (A) Sys-
tem A activity. (B) Hybridization signals for ATA2 mRNA and
GAPDH mRNA. (C) Relative abundance of ATA2 mRNA
after adjustment for variations in RNA loading by using
GAPDH mRNA levels as the internal control.
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ma membrane and a chronic phase involving activa-
tion of the transporter gene. A possible role of gene
activation has been suggested previously as a mech-
anism of adaptive regulation of system A [3^5]. The
present study provides unequivocal evidence for this
mechanism. The involvement of protein recruitment
in the adaptive regulation of system A is a novel
¢nding in the present study. This may have relevance
to the insulin-induced increase in system A activity in
skeletal muscle [3^5]. Since insulin increases glucose
transport in this tissue acutely by enhancing recruit-
ment of preformed GLUT4, a similar mechanism
may operate in the activation of system A in this
tissue. Another interesting ¢nding from the present
study is the ability of MeAIB to reverse the activa-
tion of ata2 gene expression induced by amino acid
starvation. Previous studies have shown that MeAIB,
though a non-metabolizable amino acid substrate for
system A, is capable of reversing the increase in sys-
tem A activity induced by amino acid starvation [5].
However, the underlying mechanism was thought to
be trans-inhibition, a kinetic phenomenon that has
no direct relevance to the process of adaptive regu-
lation. The present study argues against this notion.
MeAIB, though a non-metabolizable amino acid, is
able to regulate the expression of the gene coding for
ATA2. This raises an interesting question as to the
mechanism involved in the process. It appears that
the binding and translocation of the substrate via
ATA2, irrespective of whether or not the substrate
is metabolizable, is su⁄cient to provide the necessary
signal to the cell to regulate the expression of the
gene coding for the transporter. A possible mecha-
nism for such a process may involve conformational
Fig. 5. Laser-scanning confocal microscopic immunolocalization of ATA2. C6 glioma cells were exposed either to a complete medium
(A, B, E and F) or to an amino acid-free medium (C, D, G and H) for 1 h (A, B, C and D) or 8 h (E, F, G and H). Fluorescent im-
munolocalization was carried out with an antibody speci¢c for rat ATA2. Optical sections were taken in a vertical plane (x and z)
(A, C, E and G) as well as in a horizontal plane (x and y) (B, D, F and H).
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changes in the transporter protein induced by sub-
strate binding and translocation which might in£u-
ence the interaction of the protein with other signal-
ing molecules inside the cell. Alternatively, there may
be an amino acid sensor inside the cell that detects
the intracellular concentrations of amino acids and
transmits the signal to the nucleus to regulate ata2
gene expression.
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